Advertisement

Intensive Care Medicine

, Volume 41, Issue 1, pp 131–133 | Cite as

Understanding the HPA response to critical illness: novel insights with clinical implications

  • Eva Boonen
  • Greet Van den Berghe
Understanding the Disease

The stress response, essential for life during health and disease, is governed by the hypothalamus–pituitary–adrenal (HPA) axis. It starts by hypothalamic CRH release which, via the hypophyseal portal system, activates the corticotrophs in the anterior pituitary gland to secrete ACTH. ACTH stimulates steroidogenesis by binding to the melanocortin-2 receptor on adrenocortical cells. ACTH upregulates expression of this receptor and mediates cholesterol release from lipid droplets while activating expression of genes encoding proteins for cholesterol uptake and synthesis [1, 2, 3, 4, 5]. ACTH also increases expression of genes encoding key steroidogenic enzymes [1, 2, 3, 4, 5]. Besides this feedforward activation of cortisol secretion, feedback inhibition of CRH and ACTH by cortisol occurs at the pituitary and hypothalamic level.

Within this classical stress response concept, the hypercortisolemia of critical illness is thought to be brought about by elevated circulating ACTH which...

Keywords

Critical Illness Cortisol Production Plasma Cortisol Concentration Relative Adrenal Insufficiency Plasma ACTH Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

Supported by the Fund for Scientific Research Flanders, Belgium (FWO G.0417.12 to GVdB); by the Methusalem Program of the Flemish Government to GVdB via the KU Leuven University (METH/08/07) and by an ERC Advanced grant (AdvG-2012-321670) to GVdB from the Ideas Program of the European Union 7th framework program.

Conflicts of interest

Nothing to declare.

References

  1. 1.
    Lebrethon MC, Naville D, Begeot M, Saez JM (1994) Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II. J Clin Invest 93:1828–1833PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Lehoux JG, Lefebvre A, Belisle S, Bellabarba D (1989) Hormonal regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA in the rat adrenal gland. J Steroid Biochem 34:379–384PubMedCrossRefGoogle Scholar
  3. 3.
    Lehoux JG, Fleury A, Ducharme L (1998) The acute and chronic effects of adrenocorticotropin on the levels of messenger ribonucleic acid and protein of steroidogenic enzymes in rat adrenal in vivo. Endocrinology 139:3913–3922PubMedGoogle Scholar
  4. 4.
    Liu J, Heikkila P, Meng QH, Kahri AI, Tikkanen MJ, Voutilainen R (2000) Expression of low and high density lipoprotein receptor genes in human adrenals. Eur J Endocrinol 142:677–682PubMedCrossRefGoogle Scholar
  5. 5.
    Stocco DM, Clark BJ (1996) Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev 17:221–244PubMedGoogle Scholar
  6. 6.
    Annane D, Maxime V, Ibrahim F, Alvarez JC, Abe E, Boudou P (2006) Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 174:1319–1326PubMedCrossRefGoogle Scholar
  7. 7.
    Vermes I, Beishuizen A, Hampsink RM, Haanen C (1995) Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 80:1238–1242PubMedGoogle Scholar
  8. 8.
    Boonen E, Vervenne H, Meersseman P et al (2013) Reduced cortisol metabolism during critical illness. N Engl J Med 368:1477–1488PubMedCrossRefGoogle Scholar
  9. 9.
    Polito A, Sonneville R, Guidoux C et al (2011) Changes in CRH and ACTH synthesis during experimental and human septic shock. PLoS One 6:e25905PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Gibbison B, Angelini GD, Lightman SL (2013) Dynamic output and control of the hypothalamic-pituitary-adrenal axis in critical illness and major surgery. Br J Anaesth 111:347–360PubMedCrossRefGoogle Scholar
  11. 11.
    Deutschman CS, Raj NR, McGuire EO, Kelz MB (2013) Orexinergic activity modulates altered vital signs and pituitary hormone secretion in experimental sepsis. Crit Care Med 41:e368–e375PubMedCrossRefGoogle Scholar
  12. 12.
    Boonen E, Meersseman P, Vervenne H et al (2014) Reduced nocturnal ACTH-driven cortisol secretion during critical illness. Am J Physiol Endocrinol Metab 306:E883–E892PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Boonen E, Langouche L, Janssens T, Meersseman P, Vervenne H, De Samblanx E, Pironet Z, Van Dyck L, Vander Perre S, Derese I, Van den Berghe G (2014) Impact of duration of critical illness on the adrenal glands of human intensive care patients. J Clin Endocrinol Metab. doi: 10.1210/jc.2014-2429
  14. 14.
    Boonen E, Bornstein SR, Van den Berghe G (2014) On the controversy of adrenal (dys)function during critical illness: new insights. Lancet Diabetes Endocrinol (in press)Google Scholar
  15. 15.
    Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E (2000) A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 283:1038–1045PubMedCrossRefGoogle Scholar
  16. 16.
    Venkatesh B, Cohen J (2011) Adrenocortical (dys)function in septic shock—a sick euadrenal state. Best Pract Res Clin Endocrinol Metab 25:719–733PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg and ESICM 2014

Authors and Affiliations

  1. 1.Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular MedicineKU Leuven UniversityLeuvenBelgium

Personalised recommendations